GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Jianmin Pharmaceutical Group Co (SHSE:600976) Future 3-5Y EPS without NRI Growth Rate : 33.56 (As of May. 29, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Jianmin Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate is 33.56.

Competitive Comparison of Jianmin Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jianmin Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Jianmin Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Jianmin Pharmaceutical Group Co  (SHSE:600976) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Jianmin Pharmaceutical Group Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jianmin Pharmaceutical Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
SZSE:002907 SZSE:002349 SZSE:000078 SZSE:002437 SHSE:603367 SZSE:002365 SZSE:301277 SHSE:688553 SHSE:600530 SZSE:300039 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Website
http://www.whjm.com
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
Executives
Du Ming De Director
He Qin Director
Gao Kai senior management
Wang Jun senior management
Huang Zhi Jun senior management
Pei Xue Jun senior management
Bu Zhong Jiang Director
Cheng Chao Yang senior management
Xu Sheng senior management
Hu Zhen Bo senior management
Liu Qin Qiang Director
Xiong Fu Liang senior management
Liu Peng senior management

Jianmin Pharmaceutical Group Co Headlines

No Headlines